⏱ 16 min read
Hospital 366 Days · Case No. 11
The hospital’s year does not end at 365. It runs to 366, and keeps going.
Call him Wade. Age, occupation, location, and any potentially identifying details have been changed. The clinical pattern is a composite reconstructed from cases that American emergency rooms see repeatedly over a year, and it does not represent any specific patient.
Obesity hypoventilation syndrome is classified on medical charts as a chronic respiratory disease. But the way it ends is different from other chronic respiratory diseases. The damage is mostly silent during the day. It builds at night, as carbon dioxide climbs and the heart starts to fail. Without treatment, about 23% of patients with obesity hypoventilation syndrome die within 18 months in published cohort data. Average BMI at the time of death is around 40. (Nowbar 2004)
This patient arrived at the emergency department at BMI 68. The U.S. adult male average BMI is approximately 30. (NHANES) His BMI was more than twice the population average. At 5’7″, that came out to about 432 lb (196 kg). He was 36 years old. For the past five years, he had been on a nasal cannula at home around the clock, 2 liters per minute. Two years ago, he had been diagnosed with congestive heart failure and prescribed furosemide (Lasix) 60 mg twice daily. He hadn’t been taking it on schedule for several months.
The reason he wasn’t taking it was simple. Each dose meant a sharp jump in bathroom trips. At BMI 68, getting up from a recliner, untangling the oxygen tubing, and walking down a hallway to the bathroom isn’t free. It takes time, oxygen reserve, and effort. There’s a ceiling on how many times the body can do that in a day. So on days when he had to leave the apartment (work shifts, doctor’s appointments), he skipped the dose. That pattern continued for months.
On arrival, his chest X-ray showed mild pulmonary edema. Troponin moved from 28 to 32 ng/L over three hours. Pro-BNP was 510 pg/mL. Glucose 138 mg/dL, total bilirubin 1.3. No single value was alarming on its own. BNP and pro-BNP, though, are suppressed in obesity. Plasma levels run 30% to 50% lower than in normal-weight patients at the same fluid status. (Madamanchi 2014) A pro-BNP of 510 in a BMI 68 patient doesn’t mean the same thing as 510 in a patient of average build. Combined with the imaging, the rising troponin, and the months of skipped doses, the picture was decompensated heart failure on top of chronic obesity hypoventilation syndrome.
This isn’t the path most 36-year-old American men are on. It’s what late-stage obesity hypoventilation syndrome looks like by the numbers. It’s also what an everyday catch-22 looks like in a body that’s out of margin. Every day, he chose between moving around now and breathing later. Those small choices added up. They showed up on the chart on day seven, not day one. Below are the seven days that landed him in the ER.
Thirty Seconds at the ED’s Sliding Doors
April 23, 3:42 a.m. Wade paused at the sliding doors of the emergency department. From the curb where his mother had dropped him off to the doors was about 25 feet of pavement. He stopped twice on that stretch to catch his breath. The portable oxygen tank was heavy in his left hand. The nasal cannula tubing trailed behind him on the pavement. A wheelchair was already waiting just inside the doors. The night clerk had seen him approach through the glass.
His pulse oximeter showed 89%. His baseline at home, at rest, on 2 liters, was around 91%. The 2-point drop was the only number he could read on the wall display from the wheelchair. He had spent the previous week sleeping upright in his recliner. Three nights earlier, he had turned his home oxygen flow up from 2 to 4 liters without calling the supply company. The dial moved easily.
The triage nurse picked up her clipboard. “Emergency contact?” Wade gave his mother’s number. She was 62, a former schoolteacher, lived eleven minutes away by car, and had driven him here. “Family contact?” Same number. “Primary care physician?” Wade paused. “I don’t have one. The pulmonologist who set up my oxygen sees me once a year. He handles the heart failure too.” The nurse wrote that down. “Allergies?” None. “Last surgery?” Wisdom teeth, five years ago. The nurse moved on to social history. Non-smoker. No alcohol.
Wade was 36, a freight dispatcher on the overnight shift, 10 at night to 6 in the morning. He had started as a long-haul truck driver at 19 and put on his first 80 pounds eating truck-stop food over five years on the road. At 24, he had moved to a dispatch desk after a cardiologist (his first, before the current clinic) told him driving long hours at his weight was no longer safe. The dispatch job paid less but kept him seated within ten feet of a bathroom. From 24 to 31, his weight kept climbing slowly. At 31, he got his obesity hypoventilation syndrome diagnosis from his current pulmonologist. The BiPAP machine and the home oxygen tank arrived in the same week. At 34, congestive heart failure was added to the chart. The year before that, he had moved into a single-floor rental. He could no longer manage a flight of stairs.
His mother visited every Sunday with groceries. She cooked at her house and brought meals over in glass containers, enough for the week. Two friends came by the apartment about once a month. Tony was a high school friend who still lived in the same town. Greg was another night dispatcher from work. They watched movies or played co-op games on Wade’s PC. His last time outside the apartment had been his pulmonology follow-up six months earlier. He had skipped his furosemide the day before that appointment too, to keep the bathroom situation manageable for the round trip.
The triage nurse keyed in the workup orders. Cardiac enzymes. Pro-BNP. Comprehensive metabolic panel. Arterial blood gas. Chest X-ray. Bedside lung ultrasound (the available CT scanner couldn’t accommodate him). 12-lead EKG. Wade’s mother sat in the lobby. The clock above her read 4:01 a.m.
Seven Days: How Fluid Filled His Lungs
April 16 (Wednesday, Day 0). Wade was getting ready for the night shift. He had taken his morning furosemide at 7 a.m. before sleeping. He woke at 4 p.m., ate a sandwich his mother had left, and counted out the evening dose. The bottle sat on the kitchen counter next to his coffee maker. He paused. His shift started at 10 p.m., and a 60 mg dose at 8 p.m. would mean three to four bathroom trips during the first half of the shift. The dispatch office had one shared bathroom in the building hallway. He set the pill down on the counter and made coffee instead.
April 17 (Thursday, Day 1). He came home at 6:30 a.m. and skipped the morning dose too. He had been awake all night and wanted to sleep. The doctor’s instructions said morning and evening. He lived on a night schedule. He had been making this same decision for months. Nobody had ever adjusted his prescription to fit his shift.
April 18 (Friday, Day 2). Skipped the morning dose again. His feet were noticeably swollen by mid-afternoon. He sat in the recliner and propped them up on the ottoman. Tony texted to ask if he wanted to come over Saturday for a movie. Wade said yes. He added, “Maybe early afternoon.”
April 19 (Saturday, Day 3). No work shift. He took both doses for the first time in three days. Eight bathroom trips between morning and evening. The swelling in his feet was noticeably better by evening. Tony came over at 2 p.m. and left at 5. They watched half of a movie. Wade fell asleep in the recliner about an hour in.
April 20 (Sunday, Day 4). His mother arrived at 11 a.m. with groceries. He took the morning dose before she came. He skipped the evening dose so he could go to bed early without bathroom interruptions. It felt like a reasonable trade-off.
April 21 (Monday, Day 5). Back on shift Monday night. He skipped the morning dose. Around 3 a.m. mid-shift, sitting at the dispatch desk, he noticed he was short of breath even at rest. He turned the home oxygen up from 2 to 3 liters when he got back to the apartment at 6:45 a.m. His own pulse oximeter at home showed 88%. He thought he might be coming down with something.
April 22 (Tuesday, Day 6). Called in sick to dispatch. Took the morning furosemide. By afternoon, he had been to the bathroom eight times. He had a pulmonology follow-up scheduled for Wednesday afternoon. To make the drive possible, he skipped the evening dose. He went to bed at 10 p.m. By midnight, he was sitting up in the recliner because lying flat made him cough. By 2 a.m., he had increased the home oxygen to 4 liters and his pulse oximeter showed 87%. He called his mother at 3:10 a.m. She arrived at 3:30. They reached the emergency department at 3:42 a.m.
Obesity Hypoventilation Syndrome Decompensation: What the ED Workup Confirmed
Triage time 3:42 a.m. Vitals: blood pressure 158/94, heart rate 112, respiratory rate 24, pulse oximetry 89% on 4 liters by nasal cannula, temperature 36.8°C. No fever.
Lab results: WBC normal. Troponin 28 ng/L, repeat at 3 hours 32 (mildly above the reference upper limit of 14). Pro-BNP 510 pg/mL. Total bilirubin 1.3 (near upper limit). Glucose 138 mg/dL (consistent with known non-insulin-dependent diabetes, non-fasting). Creatinine normal. Comprehensive metabolic panel otherwise unremarkable.
Arterial blood gas: pH 7.34, PaCO2 56 mmHg (consistent with chronic hypercapnia in obesity hypoventilation syndrome), PaO2 64 mmHg (on 4 liters), HCO3 31 mEq/L (chronic metabolic compensation).
Imaging: Chest X-ray showed bilateral mild pulmonary edema, cardiomegaly, and elevated hemidiaphragms (consistent with abdominal mass effect from morbid obesity). CT wasn’t performed because the available scanner couldn’t accommodate him. Bedside lung ultrasound was used instead, showing bilateral B-lines and small bilateral pleural effusions. EKG showed sinus tachycardia, left ventricular hypertrophy, and a right heart strain pattern.
Taken together, the imaging and labs were consistent with chronic obesity hypoventilation syndrome decompensating into acute heart failure over about a week. The mildly rising troponin pointed more toward right ventricular strain than acute MI, but the upward trend wasn’t something to ignore.
The ED physician entered the following orders: IV furosemide 80 mg push followed by continuous infusion at 10 mg/hr. BiPAP application (Wade used a home BiPAP at night, so the interface was familiar). Telemetry monitoring. Cardiology consult. Pulmonology consult. Admission to the cardiology telemetry floor.
| Clinical Metric / Term | Patient’s Presentation | Pathophysiological Mechanism & Reference Literature |
|---|---|---|
| Obesity Hypoventilation Syndrome | BMI 68, PaCO2 56 | Defined by BMI ≥30 plus daytime hypercapnia (PaCO2 ≥45 mmHg) plus sleep-disordered breathing. 18-month untreated mortality ~23% (Nowbar 2004); subsequent cohorts with adherent PAP report substantially better survival (Priou 2010, Castro-Anon 2015). |
| BMI 68 (Super-Super Obesity) | 5’7″ / 432 lb | BMI ≥60 is classified as super-super obesity in bariatric surgery and critical care literature. NHANES estimates approximately 0.2 to 0.3% of U.S. adults have BMI ≥60. Each 5-unit BMI rise above 30 is associated with measurable increases in all-cause mortality (Berrington 2010). |
| BNP Suppression in Obesity | Pro-BNP 510 | Adipose tissue clears BNP via the NPR-C receptor. Plasma levels run 30% to 50% lower in severe obesity at equivalent fluid status (Madamanchi 2014). Wade’s 510 corresponds to a corrected estimate of roughly 750 to 1,000. |
| Chronic Hypercapnia | PaCO2 56, HCO3 31 | Sustained CO2 retention with metabolic compensation. Develops over months. Most pronounced during sleep, which explains the disproportionate share of OHS deaths that occur at night. |
| Diuretic Non-adherence | ~5 of 14 doses skipped / 7 days | Medication non-adherence is a leading precipitating factor for CHF readmission (Fonarow 2008). Median time from onset of skipped doses to clinical decompensation is 5 to 10 days. |
| Right Ventricular Strain | Troponin 28→32, EKG strain | Chronic OHS causes pulmonary hypertension and RV hypertrophy, producing low-grade persistent troponin elevation. Acute volume overload amplifies the demand mismatch. The rising trend, more than the absolute value, was the signal here. |
Seven days of skipped doses, two organ systems already under strain, and a chest X-ray that still read “mild.”
From the Reviewer · Eleanor Hayes, M.D.
(A) A chronic respiratory disease that kills during sleep
When a chart says “chronic respiratory disease,” most patients picture COPD or asthma. Symptoms show up while the patient is awake. Coughing during the day, shortness of breath on exertion. Obesity hypoventilation syndrome doesn’t behave that way. What defines it is that the most dangerous changes happen during sleep. The patient lies flat. The abdominal mass pushes up against the diaphragm. Tidal volume drops, CO2 rises, and chronic exposure dulls the brain’s CO2 sensitivity. The cardiovascular system takes the load. The patient wakes up not knowing what happened. The 23% 18-month mortality among untreated patients in Nowbar’s 2004 cohort isn’t a slow decline the patient can see coming. It includes a meaningful share of deaths that occur at night, in bed.
(B) What BMI 68 actually means clinically
BMI above 60 is sometimes labeled super-super obesity, an informal category used in bariatric surgery and critical care literature. BMI 65 and above shows up more in case reports than in population studies. NHANES estimates that approximately 0.2 to 0.3% of U.S. adults have BMI ≥60. At this range, the patient has run down physiological reserve in multiple systems at once. Respiratory mechanics, cardiac filling pressures, glycemic control, joint loading, vascular endothelium: none of these can be evaluated using reference ranges built around BMI 25 to 30. Wade’s troponin of 28 to 32 looks small in absolute numbers, but the reference ranges used to interpret it were built on patients whose physiology is different from his. The same number means a different thing at BMI 68 than at BMI 27.
(C) The bathroom and the diuretic: a daily calculation
Oral furosemide begins acting within 30 to 60 minutes, peaks at 1 to 2 hours, and produces diuresis for 4 to 6 hours after a 60 mg dose. Two doses spread across a day put the patient at the toilet 6 to 10 times. In an average-weight ambulatory patient, this is inconvenient. In a patient at BMI 68, with single-floor housing, oxygen tubing to manage, and an overnight shift, it becomes a real reason not to leave the apartment. Wade’s decision to stop taking it wasn’t random and wasn’t careless. It was a daily cost-benefit calculation, repeated for months. The physiology, though, runs on a different clock. When the daily dose is skipped, sodium and water retention build up over 24 to 72 hours, and the lungs fill in by day five to seven. Wade’s seven days were textbook.
(D) 24/7 home oxygen at 36: what published cohorts show
Long-term oxygen therapy at home is most commonly prescribed for COPD patients in their 60s and 70s. Patients under 40 on continuous home oxygen are a small fraction of the LTOT cohort. Obesity hypoventilation syndrome accounts for a growing share of that under-40 group as severe obesity prevalence rises in the U.S. Five-year survival on 24/7 home oxygen varies by underlying disease. For COPD, it’s approximately 50% (NOTT and MRC trial extensions). For obesity hypoventilation syndrome with adherent PAP therapy, prospective follow-up cohorts (Priou 2010) report 5-year survival in the 70% to 80% range. Wade was 31 when he first got an oxygen prescription. He has now spent approximately 14% of his life on continuous home oxygen. The question now isn’t whether he’ll need oxygen. It’s what the next 10 years look like.
(E) Why pro-BNP 510 in this patient is not pro-BNP 510 in another patient
A pro-BNP of 510 in a normal-weight 36-year-old with mild shortness of breath wouldn’t, on its own, lead to admission. The same number in a BMI 68 patient is read differently because of a well-known pharmacokinetic effect. Adipose tissue expresses the natriuretic peptide receptor C, which clears circulating BNP, so plasma concentrations are 30% to 50% lower in severely obese patients at equivalent ventricular wall stress (Madamanchi 2014). Several heart failure guidelines now recommend lowering BNP thresholds for diagnosis by approximately 50% in patients with BMI ≥35. Wade’s 510 corresponds to a corrected estimate of roughly 750 to 1,000 if read against an average-build patient. Those numbers would prompt admission. 510 on its own wouldn’t. Which threshold the clinician applies makes the call.
(F) Mild troponin elevation and the right ventricle
Wade’s troponin moved from 28 to 32 ng/L on a high-sensitivity assay with a reference upper limit of 14. The trend was upward, which rules out the easy explanation of chronic baseline elevation. STEMI wasn’t the working diagnosis; the EKG showed no ischemic changes. The likely source was right ventricular demand ischemia from acute decompensation layered on chronic OHS-induced pulmonary hypertension. In a younger patient without coronary disease, this pattern is more often overlooked than acted on, because the absolute number stays low. What mattered here was the rate of rise more than the absolute value.
(G) When chart age and cardiopulmonary age diverge
A 36-year-old without baseline cardiac disease showing up with Wade’s labs would normally be triaged as low to moderate acuity. The same labs in a 65-year-old with diabetes and coronary disease would trigger immediate admission. Wade sits in a third category. He’s young, but his cardiopulmonary system is older than his chart age. Labs that look mild on paper aren’t mild against his baseline physiology. The mental shortcut “young equals stable” isn’t safe in the BMI 60+ population. Physiology, more than chart age, should set the threshold for admission, imaging, and consult.
(H) Inpatient versus outpatient intensification
For most CHF decompensations, oral diuretic intensification at home is the first step. The criteria for admission instead of outpatient management are well-defined: hypoxia not responsive to home oxygen titration, evidence of organ dysfunction (rising troponin, hypotension), inability to tolerate oral medication, or social and structural factors that make reliable outpatient titration unlikely. Wade met two of those criteria on arrival. His pulse oximetry hadn’t responded to his self-escalation to 4 liters. His troponin was rising. His self-titration history alone made outpatient management an unreliable plan. The decision to admit was straightforward. The expected length of stay was 3 to 5 days, depending on diuretic response and whether BiPAP titration needed adjustment.
(I) What the published trajectories show when adherence doesn’t change
When obesity hypoventilation syndrome decompensates and the patient gets sent home rather than admitted, or admitted but discharged back into the same outpatient pattern, the published literature shows the following.
Short-term progressions (next 30 days to 12 months):
- 30-day rehospitalization for the same decompensation in CHF non-adherence: approximately 25% in U.S. data (Krumholz 2009 and OPTIMIZE-HF).
- 1-year mortality after a first OHS-related hospitalization: 15% to 20% across mixed cohorts.
- 18-month mortality for untreated obesity hypoventilation syndrome: 23% (Nowbar 2004). Adherent PAP therapy in subsequent prospective cohorts (Priou 2010, Castro-Anon 2015) is associated with substantially lower mortality, with some series reporting 5-year survival above 70%.
Severe progressions:
- Acute hypercapnic respiratory failure requiring intubation. At BMI ≥60, difficult intubation rates are approximately 4 to 6 times higher than in average-weight patients. Failed first-pass intubation correlates with aspiration, hypoxic injury, and higher ICU mortality.
- ICU mortality once intubated for OHS with hypercapnic failure at BMI ≥60: reported between 30% and 50% in case series.
- Extubation failure rate post-intubation at BMI ≥60: approximately 25% to 30%, with a portion of those patients proceeding to tracheostomy.
- Progressive right heart failure with persistent pulmonary hypertension, eventually requiring inotropic support.
- Sudden cardiac death during sleep. The OHS literature attributes a measurable share of out-of-hospital cardiac arrests in young extreme-BMI patients to this mechanism.
Five-year projections under unmanaged trajectory:
- All-cause mortality at BMI ≥60 with untreated OHS: approximately 30% to 50% at five years.
- Cumulative inpatient days over five years: median 60 to 90 days in retrospective cohorts.
- Disability transition: a meaningful share of patients in this profile go from full employment to disability within 3 to 5 years.
- Cumulative inpatient billing: $400,000 to $700,000 in facility cost over five years. Out-of-pocket caps near the annual maximum each year, but non-medical losses (lost wages, depending on family for daily care) usually add up to more than the medical billing.
None of these numbers are predictions for any single patient. They’re the observed distribution. The curve is still open. Where a patient lands on that curve depends on what happens after discharge.
(J) Five decisions that move the curve, and what data says about each
Some of Wade’s risk can’t be reversed in the short term. A 36-year-old body that’s been at BMI 60+ for five years isn’t going to be a different body in six weeks. Other parts can be changed from here. Five decisions are available in the outpatient window after this admission. Real options with measurable effects later on.
- A furosemide adherence system built around bathroom logistics. The functional barrier is bathroom timing, more than the medication itself. A patient-built schedule reduces self-discontinuation. Adherence interventions in CHF have reduced 30-day readmission by approximately 20% to 40% across randomized trials.
- Nightly BiPAP use of at least 4 hours. Adherent PAP therapy in obesity hypoventilation syndrome has been associated with substantially lower mortality in long-term follow-up (Priou 2010, Castro-Anon 2015). Five-year survival has been reported above 70% in adherent cohorts, against an 18-month untreated mortality near 23% (Nowbar 2004).
- Pulmonary rehabilitation. Even at BMI 68, structured supervised rehab using seated cardiopulmonary exercise has been linked to lower one-year rehospitalization rates. The evidence is stronger in COPD than in OHS specifically at this point.
- Anti-obesity pharmacotherapy consult. GLP-1 receptor agonists (semaglutide, tirzepatide) at maximum tolerated doses have shown 15% to 20% total body weight loss at about one year in clinical trials. At BMI 68, a 15% loss reduces BMI to approximately 58, moving him below the super-super obesity range.
- Bariatric surgery consult. Sleeve gastrectomy and gastric bypass have demonstrated 25% to 35% total body weight loss at five years and reduced all-cause mortality in observational data, even after accounting for perioperative risk that runs approximately 1% to 2% at BMI ≥60.
The decision among these five is the patient’s and the team’s. The data above is what the curves look like before that decision. None of these five can be answered in an emergency department.
Two Costs, One Decision Window
| Clinical & Behavioral Scenarios | Estimated Facility Billing | Patient Out-of-Pocket (PPO) |
|---|---|---|
| (1) Actual cost of the 5-day admission for decompensated obesity hypoventilation syndrome | $35,000 to $60,000 | ~$8,500 (annual OOP max hit) |
| (2) Hypothetical: adherent outpatient titration (Lasix on schedule, BiPAP nightly, monthly follow-up) | $300 to $800 / month (routine outpatient) |
~$30 to $60 (copays only) |
| (3) Add: one ICU stay for hypercapnic respiratory failure (next 12 months if pattern unchanged) | +$120,000 to $250,000 | OOP max re-hit (new plan year) |
| (4) Five-year projection: 2 to 3 admissions per year, partial ICU exposure, no behavioral change | +$400,000 to $700,000 | Annual OOP max + disability risk |
Sources: Nowbar 2004 (OHS mortality); Krumholz 2009 (CHF readmission).
For a PPO member who hits the annual out-of-pocket maximum every year, the dollar difference between scenarios flattens out quickly. The variable that doesn’t flatten out is time. The 5-day admission completed one diuresis cycle and re-stabilized one episode of decompensation. What happens over the next 30 days, 18 months, and 5 years is decided by the outpatient calendar that begins when the patient walks out of the hospital.
The same pattern of skipping a daily medication for daily-life reasons shows up in the case of a man who stopped his blood pressure medication and arrived in heart failure. The same absence of a primary care relationship at a critical decision point shows up in the hidradenitis suppurativa case. The same isolation-as-medical-variable pattern shows up in the older men living alone case.
Tools for Reading Body and Heart Numbers
At BMI 68, standard reference ranges read differently than they do at BMI 25. Three calculators that can help frame the numbers against age-matched references that take body composition into account.
· Body Truth Calculator (BMI & Metabolic Risk Matrix)
· Heart Age Calculator (Vascular Aging Predictor)
· Life Calculator (Cardiopulmonary Longevity Estimate)
Wade was discharged on day 5 of admission. His pulse oximetry on his usual 2 liters had stabilized in the 91% range, the chest X-ray showed clearing of the pulmonary edema, and his troponin had drifted back to baseline. His pro-BNP had fallen to 380. His weight on the floor scale was 12 pounds below his admission weight, all of it fluid.
His mother picked him up. The discharge envelope held appointments for five outpatient visits. Pulmonology in 4 weeks. Cardiology in 6 weeks. A bariatric medicine consult to discuss anti-obesity pharmacotherapy in 3 weeks. A pulmonary rehab evaluation in 2 weeks. A registration form for a primary care physician with a clinic phone number circled in blue ink.
In the car on the way home, Wade asked his mother to stop at a pharmacy. He had her go in and refill the furosemide. He moved the new bottle from his kitchen counter to his nightstand that evening. On his phone, he set a recurring alarm for 7 a.m. and another for 7 p.m. He bought a pill organizer the next day. Tony texted to ask how it had gone. Wade said: “Five days in. Five appointments out. We’ll see.”
The five decisions ahead of him can’t be answered in an emergency department. The emergency department finished one diuresis cycle and re-stabilized one episode of decompensation. The trajectory described in section (I) of the reviewer’s notes, and the alternative described in section (J), depend on what happens over the next 12 weeks in his apartment and his pulmonologist’s office. This case doesn’t show what every 36-year-old American man should expect. It shows what late-stage obesity hypoventilation syndrome looks like by the numbers, and what choices fill the outpatient calendar starting on day 6.
This article is for general information and does not provide medical advice. The case described is a composite reconstructed from publicly reported clinical patterns and does not represent any specific patient. New or worsening shortness of breath, leg swelling, or needing to sleep upright because lying flat causes breathlessness should prompt a call to a primary care physician or an emergency department visit. Prescribed diuretics should not be stopped or modified on your own.
Take care of yourself. Nobody else will do it for you.
Wilbur P is the editor of Manclub, leading coverage across health and life. His work is research-driven and built on primary sources a reader can verify – written for men in the second half of life who would rather know than believe. Based in Florida, still learning and still in the fight. Corrections, questions, story tips: [email protected].